MOTS-C

Description

MOTS-c

MOTS-c is a naturally occurring mitochondrial-derived peptide consisting of 16 amino acids and encoded by a short open reading frame within the mitochondrial 12S ribosomal RNA region. The name MOTS-c refers to “mitochondrial open reading frame of the 12S rRNA type-c.” Unlike conventional peptides encoded by nuclear DNA, MOTS-c is produced from mitochondrial genetic material, making it part of a relatively new class of signaling molecules known as mitochondrial-derived peptides (MDPs).

Scientific interest in MOTS-c has grown because experimental studies suggest that it may participate in communication between mitochondria and the rest of the cell. Research has investigated its possible involvement in glucose metabolism, insulin sensitivity, energy balance, cellular stress responses, aging-associated processes, and nuclear gene regulation.

The peptide has been detected in circulation and in tissues associated with mitochondrial activity, while experimental work has reported changes in its levels with age. Researchers have consequently proposed that MOTS-c may represent part of a mitochondrial signaling system that helps cells respond to metabolic stress.

Specifications

Other Known Titles: MOTS-c, Mitochondrial ORF of the 12S rRNA Type-C
Sequence: MRWQEMGYIFYPRKLR
Length: 16 amino acids
Molecular Formula: C101H152N28O22S2
Molecular Weight: 2174.6 g/mol
CAS Number: 1627580-64-6

MOTS-c Research

MOTS-c and Metabolic Regulation

One of the earliest and most extensively studied properties of MOTS-c concerns metabolic regulation. Initial research identified the peptide as a mitochondrial-derived signal capable of influencing metabolic homeostasis, particularly in skeletal muscle.

Experimental studies investigated MOTS-c in cellular systems and mouse models and reported effects involving insulin sensitivity and glucose utilization. Researchers proposed that the peptide may influence metabolic pathways by interacting with folate-dependent metabolism and purine biosynthesis, ultimately affecting AMP-activated protein kinase (AMPK) activity.

AMPK is an important cellular energy sensor that responds to changes in the availability of energy within cells. Because this pathway participates in glucose and lipid metabolism, its relationship with MOTS-c has become an important area of investigation.

The available findings have generated interest in MOTS-c as a molecular model for studying how mitochondria may communicate information about cellular energy status. However, much of the mechanistic evidence remains preclinical.

MOTS-c and Insulin Sensitivity

Insulin resistance is characterized by a reduced biological response to insulin and is an important component of metabolic disorders. Researchers have examined MOTS-c because of observations suggesting that mitochondrial signaling may influence insulin responsiveness.

In experimental mouse studies, administration of MOTS-c was associated with protection against insulin resistance produced by aging or high-fat feeding. The original research suggested that skeletal muscle may represent an important site of action for the peptide.

These findings have led to further investigation into whether MOTS-c can influence glucose uptake and metabolic flexibility. Researchers have also explored the relationship between MOTS-c and AMPK-associated signaling, which may help explain some of the metabolic responses observed in experimental models.

Although these findings are scientifically significant, animal-model results should not be interpreted as proof that MOTS-c treats insulin resistance or diabetes in humans.

MOTS-c and Glucose Metabolism

Glucose metabolism is another major field of MOTS-c research. Skeletal muscle plays a substantial role in whole-body glucose disposal, and mitochondrial function within muscle cells is closely linked to energy metabolism.

Experimental work has suggested that MOTS-c can influence pathways involved in glucose handling. Researchers have investigated whether these effects are connected with AMPK activation and changes in cellular metabolic activity.

Reviews of mitochondrial-derived peptides have highlighted MOTS-c as a potentially important regulator of glucose homeostasis and have discussed its possible relevance to metabolic disorders.

Further studies are required to determine the precise molecular sequence of events responsible for these effects and whether observations from experimental models can be reproduced consistently in humans.

MOTS-c and Obesity Research

MOTS-c has also been examined in models of obesity and diet-induced metabolic dysfunction. In the original animal research, treatment with the peptide was reported to reduce the development of obesity and insulin resistance associated with high-fat feeding.

These observations have encouraged researchers to explore the connection between mitochondrial signaling, energy expenditure, nutrient utilization, and body-weight regulation.

The proposed role of MOTS-c is particularly interesting because mitochondria are central to cellular energy production. A peptide originating from mitochondrial DNA could therefore provide a mechanism through which mitochondria communicate their metabolic condition to other cellular systems.

Despite these experimental observations, MOTS-c should not be considered an established weight-management therapy. Its potential relationship with obesity remains an active area of research.

MOTS-c and Cellular Stress

MOTS-c has been investigated as a potential mediator of cellular responses to metabolic stress. One notable feature of the peptide is its ability, under certain stress conditions, to relocate from mitochondria-associated cellular compartments toward the nucleus.

Research has suggested that this movement may allow MOTS-c to influence nuclear gene-expression programs involved in cellular adaptation. In particular, studies have proposed that MOTS-c can act as a mitochondrial-to-nuclear signaling molecule when cells experience metabolic stress.

This mechanism has contributed to the concept that mitochondria are not simply energy-producing organelles but also active signaling structures capable of regulating nuclear responses.

Further investigation is needed to determine which nuclear targets are directly controlled by MOTS-c and how these responses vary between different cell types.

MOTS-c and Aging Research

Age-related changes in mitochondrial function have become an important subject in longevity research. Because MOTS-c originates from mitochondrial DNA and participates in metabolic signaling, researchers have investigated whether its biological activity changes during aging.

Experimental and observational research has reported relationships between MOTS-c levels and age-related metabolic changes. Reviews have discussed reduced circulating MOTS-c concentrations with increasing age and have proposed that the peptide may participate in biological processes connecting mitochondrial function with aging.

Researchers have consequently explored MOTS-c in models involving age-associated insulin resistance, metabolic dysfunction, and cellular stress.

The relationship between MOTS-c and longevity remains investigational. Changes in peptide concentration with age do not by themselves establish that restoring MOTS-c levels will increase lifespan or reverse aging.

MOTS-c and AMPK Signaling

AMPK is a central regulator of cellular energy balance and responds to changes in the ratio between available energy substrates and cellular energy requirements.

One proposed mechanism for MOTS-c involves modification of metabolic pathways leading to AMPK activation. The original metabolic study suggested that MOTS-c interferes with aspects of the folate cycle and associated purine biosynthesis, resulting in increased signaling through the AMPK pathway.

This mechanism provides a possible explanation for some of the observed effects on glucose metabolism and insulin sensitivity.

Because AMPK participates in numerous cellular processes, researchers continue to investigate whether MOTS-c affects additional metabolic pathways beyond its initially described actions.

MOTS-c and Nuclear Gene Regulation

An especially interesting aspect of MOTS-c biology is its proposed ability to influence nuclear gene expression. Although its genetic origin is mitochondrial, experimental research has demonstrated that MOTS-c can relocate to the nucleus under metabolic stress.

Studies examining this phenomenon have suggested that MOTS-c may modify transcriptional responses that help cells adapt to changing metabolic conditions. This finding provides a potential link between mitochondrial activity and nuclear regulation.

The concept is significant because it suggests that mitochondrial-derived peptides may function as signaling messengers rather than merely representing by-products of mitochondrial gene expression.

MOTS-c and Cardiometabolic Research

MOTS-c has attracted interest in cardiometabolic research because mitochondrial dysfunction, insulin resistance, obesity, and cardiovascular disease share several biological pathways.

Reviews of mitochondrial-derived peptides have discussed experimental evidence connecting MOTS-c with metabolic and cardiovascular processes. Research has explored whether modulation of mitochondrial signaling could influence tissue responses to metabolic stress and other pathological conditions.

These findings have positioned MOTS-c as a potential research tool for studying relationships between mitochondrial metabolism and systemic physiological regulation.

Nevertheless, the evidence remains insufficient to establish MOTS-c as a clinically proven treatment for cardiovascular or metabolic disease.

MOTS-c and Tissue Protection Research

More recent experimental work has expanded MOTS-c research into tissue injury and cellular protection. A 2026 study investigated the peptide in the context of soft-tissue transplantation and reported effects involving lysosomal membrane permeability and tissue survival in experimental models.

This work adds another potential dimension to MOTS-c biology by examining how mitochondrial-derived signaling may influence cellular responses to transplantation-related stress.

Because this research is recent and experimental, additional independent studies are necessary to establish whether the observed mechanisms are reproducible and applicable across different tissues or biological conditions.

MOTS-c and Immune Research

MOTS-c research has also expanded into immune-related mechanisms. Recent work has described MOTS-c as a mitochondrial-encoded peptide with potential host-defense and immunomodulatory properties, including experimental evidence of direct antibacterial activity.

These findings are particularly notable because they broaden the proposed biological role of MOTS-c beyond metabolism. If independently confirmed, mitochondrial-derived peptides could represent an additional class of molecules linking cellular metabolism with immune defense.

However, these observations are relatively new and should be considered exploratory until replicated and characterized across additional experimental systems.

MOTS-c Research Status

MOTS-c is an important experimental example of a mitochondrial-derived peptide and has become a subject of research spanning metabolism, insulin sensitivity, obesity, cellular stress, aging, mitochondrial-to-nuclear communication, tissue protection, and immune biology.

The strongest foundational evidence comes from cellular and animal research demonstrating that MOTS-c can influence metabolic pathways and energy homeostasis. Subsequent studies have expanded the field to include nuclear signaling, aging-related biology, and other physiological processes.

For research purposes, MOTS-c is best characterized as a 16-amino-acid mitochondrial-derived signaling peptide encoded within the mitochondrial 12S rRNA region. Its diverse experimental activities make it a useful subject for investigating the relationship between mitochondrial function, metabolism, cellular stress, and systemic physiology.

Importantly, MOTS-c remains an investigational peptide. Experimental findings should not be interpreted as proof of clinical efficacy, and further controlled research is required to establish its safety, pharmacology, therapeutic potential, and long-term biological effects in humans.